Regional variation in prevalence of difficult-to-treat asthma and oral corticosteroid use for patients in Australia: heat map analysis

Peter A. B. Warka Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton, NSW, Australia

https://orcid.org/0000-0001-5676-6126

, BMed, PhD, FRACP, FThorSoc

Mark Hewb Public Health & Preventive Medicine, Monash University, Melbourne, VIC, Australia;c Allergy, Asthma & Clinical Immunology, Alfred Hospital, Melbourne, VIC, Australia

, MBBS, PhD, MScEBHC, FRACP,

Yang Xud AstraZeneca, Cambridge, UK

, BPharm,

Clare Ghislae AstraZeneca, Sydney, NSW, Australia

, BSc, MPH,

Tra-My Nguyenf ZS Associates, London, UK

, BPharm(Hons), GCertPharmPrac, MBA,

Bora Erdemlig ZS Associates, Zurich, Switzerland

, PhD,

Aditya Samantg ZS Associates, Zurich, Switzerland

, BTech &

Cassandra Nanh AstraZeneca, Mölndal, SwedenCorrespondence[email protected]

, PhD show all

Regional variation in prevalence of difficult-to-treat asthma and oral corticosteroid use for patients in Australia: heat map analysis

AUS_Heat_Map_Analysis_Manuscript_Supplemental_Information.docx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Regional variation in prevalence of difficult-to-treat asthma and oral corticosteroid use for patients in Australia: heat map analysis

AUS_Heat_Map_Analysis_Manuscript_Supplemental_Information.docx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date